Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Haematologica|February 16, 2005
Lack of receptor activator of nuclear factor-kB ligand (RANKL) expression and functional production by human multiple myeloma cellsNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Bioinformatics (Oxford, England)|September 9, 2022
A machine learning-based method for automatically identifying novel cells in annotating single-cell RNA-seq dataZiyi Li, Yizhuo Wang, Irene Ganan-Gomez, et al.
Haematologica|May 12, 2004
e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?Simona Colla, Gabriella Sammarelli, Simone Voltolini, et al.
Hematology (Amsterdam, Netherlands)|September 22, 2021
Evaluation of routine CT scans in the follow-up of diffuse large B-cell lymphomasMartí Mascaró-Pol, Ramón Díez-Feijoo, Juan Jose Rodriguez-Sevilla, et al.
Blood Advances|June 16, 2022
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuumXavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, et al.
Blood|February 17, 2007
CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanismsFenghuang Zhan, Simona Colla, Xiaosong Wu, et al.
Experimental Hematology|October 28, 2010
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxideManuela Abeltino, Sabrina Bonomini, Marina Bolzoni, et al.
Blood|June 4, 2005
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiationNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Blood|January 27, 2007
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsSimona Colla, Fenghuang Zhan, Wei Xiong, et al.
Blood|May 10, 2005
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myelomaLori A Ehrlich, Ho Yeon Chung, Irene Ghobrial, et al.
Pageof 10